Prescription drug · ANDA
Venlafaxine NDC 70771-1651
Venlafaxine hydrochloride 150 mg/1 · Tablet, Extended release · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1651-1 | 7077116510170771165101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1651-1)Marketed from Sep 1, 2022 | |
| 70771-1651-3 | 7077116510370771165103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1651-3)Marketed from Sep 1, 2022 | |
| 70771-1651-9 | 7077116510970771165109 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1651-9)Marketed from Sep 1, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Venlafaxine
- Generic name (nonproprietary)
- venlafaxine
- Active ingredients
- Venlafaxine hydrochloride — 150 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215622
- Marketing start
- Listing expires
- Other FDA classes
- Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1651_0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57SPL ID 0bf02fa2-e5cd-42d6-ab41-1ecd150b7c57SPL set ID 750333ce-a512-42e1-b9e3-179714b488dfRxCUI 808744, 808748, 808751, 808753UNII 7D7RX5A8MO
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771165101followed by a unit qualifier and the quantityPackage 70771-1651-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 70771-1651
- What is NDC 70771-1651?
- 70771-1651 is the product NDC for Venlafaxine, Venlafaxine hydrochloride 150 mg/1 tablet, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Venlafaxine.
- What is the active ingredient?
- Venlafaxine hydrochloride.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Venlafaxine?
- 118 other product NDCs are listed under this name. See all Venlafaxine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Venlafaxine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4779 | 70518-4779-00 |
| venlafaxinevenlafaxine hydrochloride | Venlafaxine hydrochloride 37.5 mg/1 | TabletOral | Coupler LLC | 67046-0560 | 67046-0560-03 |
| venlafaxine | Venlafaxine hydrochloride 50 mg/1 | TabletOral | Coupler LLC | 67046-1681 | 67046-1681-03 |
| venlafaxine | Venlafaxine hydrochloride 75 mg/1 | TabletOral | Coupler LLC | 67046-2020 | 67046-2020-03 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4566 | 70518-4566-00 |
| Venlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4500 | 70518-4500-00 |
| venlafaxine | Venlafaxine hydrochloride 75 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4168 | 70518-4168-00 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3820 | 70518-3820-00 |
| venlafaxinevenlafaxine hydrochloride | Venlafaxine hydrochloride 37.5 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-323 | 51655-0323-52 |
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-728 | 60760-0728-60 |
Other NDCs under ANDA 215622
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-4566 |
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1348 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1349 |
| Venlafaxine | Venlafaxine hydrochloride 150 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1350 |
| Venlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-1352 |
| Venlafaxine | Venlafaxine hydrochloride 37.5 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1649 |
| Venlafaxine | Venlafaxine hydrochloride 75 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1650 |
| Venlafaxine | Venlafaxine hydrochloride 225 mg/1 | Tablet, Extended releaseOral | Zydus Lifesciences Limited | 70771-1652 |